Continuous Monitoring and Management of Vaginal Health via Multifunctional OCT/OCTA Endoscopy NIH R01EB030558Sep 15, 2021 - Sep 14, 2024 Role: Co-Principal Investigator |
ARTISAN-SNM: Axonics SacRal NeuromodulaTIon System for UrinAry Urgency Incontinence TreatmeNt: A single-arm, prospective, multi-center, unblinded pivotal study to evaluate the safety and effectiveness of the Axonics Sacral Neuromodulation System as an aid in the treatment in the symptoms of urinary urgency incontinence (UUI). Axonics. $620,385.00 Mar 1, 2018 - Dec 31, 2018 |
Determination of LOXL1 and Fibulin-5 levels in the vaginal secretions in women with and without pelvic organ prolapse. ICTS Pilot 2017 - Part 1 [LOX 1]. $27,500.00 Jun 1, 2017 - Mar 31, 2018 |
Multi-center, Prospective, Randomized, Controlled, Non-Inferiority Clinical Trial of Chronic Afferent Nerve Stimulation (CAN-Stim) of the Tibial Nerve versus Sacral Nerve Stimulation (SNS) in the treatment of Urinary Urgency Incontinence resulting from Refractory Overactive Bladder (OAB) - “PROTECT” Study. Stimguard. $667,252.00 Nov 1, 2016 - Nov 30, 2019 |
Improving Urogynecology Patient Education and Discharge Process. Co- Investigator Sonia Dutta, M.D. $5000.00 Jan 1, 2016 |
A single-blind, multi-center randomized, controlled, non-inferiority, clinical study to assess the safety and performance of the Neurotech Vital Compact device compared to the itouch Sure Pelvic Floor Exerciser for the treatment of stress urinary incontinence in female patients. Principal Investigator Felicia L. Lane M.D. BIO-MEDICAL RESEARCH LTC $145,950.00 Jun 1, 2015 - Jun 30, 2018 |
University of California Irvine School of Medicine Faculty Grant. Principal Investigator Felicia Lane, M.D. Co-Investigators Emily Adams-Piper M.D. $10,000. Jan 1, 2014 - Jan 31, 2015 |
A Prospective, Non-Randomized, Parallel Cohort, Multi-Center Study of Xenform vs. Native Tissue for the Treatment of Women with Anterior/Apical Pelvic Organ Prolapse. Principal Investigator Felicia L. Lane M.D. $98,514.00 Oct 1, 2013 - Sep 30, 2016 |
Stimulation Latency Period and Optimal Cycling for Sacral Neuromodulation Patients. Principal Investigator Lauren Cadish, M.D. Co-Investigators Karen L. Noblett, M.D.; Felicia Lane, M.D.; Anthony Gaddi, M.D.; Stephanie Jacobs, M.D. $25,000 Mar 1, 2013 - Mar 31, 2015 |
A Retrospective Review of a Combined Technique for Rectovaginal Fistula Repair. Principal Investigator Felicia L. Lane M.D. Co-Investigator Jennifer K. Lee, M.D. Mar 1, 2011 - Mar 31, 2012 |
A prospective, multi-center study on the effect of sacral neuromodulation (SNM) on bowel function in women undergoing Interstim™ for refractory overactive bladder (OAB). Principal Investigator: Karen L. Noblett, M.D., Co-Investigators: Felicia L. Lane, M.D.; Jennifer K. Lee, M.D.; Danielle Markle, M.D.; Stephanie A. Jacobs, M.D. Jun 1, 2010 - Jun 30, 2011 |
A Retrospective Review of Interstim for Non-obstructive Urinary Retention: Does Nerve Testing Predict Successful Trial Stimulation? Principal Investigator: Karen L. Noblett, M.D., Co-Investigators: Felicia L. Lane, M.D.; Jennifer K. Lee, M.D.; Ene G. George, M.D.; Danielle Markle, M.D., Laura Sech, M.D. Apr 1, 2010 - Apr 30, 2011 |
Botulinum Toxin Type A to Enhance Myoblast Tranplantation for the Treatment of Anal Incontinence. Principal Investigator: Felicia L. Lane, M.D. Co-Investigators: Danielle Markle, M.D., Hans Keirstead, M.D., Gabriel Nistor, M.D., Narveet Narula, M.D. Funded by Perinatal Resource Inc. $6,262. 10/09 to 10/11 IACUC #2007-0751-1 Oct 1, 2009 - Oct 31, 2011 |
Pelvic Floor Disorders and Muscle Behavior. Principal Investigator Felicia L. Lane M.D. Co-Investigators Jocelyn B. Craig, M.D., Danielle Markle, M.D., Jennifer K. Lee, M.D., Hans Keirstead, M.D., Gabriel Nistor, M.D., Narveet Narula, M.D. Funded by Perinatal Resource Inc. $6,188. Sep 1, 2009 - Aug 31, 2011 |
Myoblast Transplantation for the Treatment of Anal Incontinence. Principal Investigator Felicia L. Lane M.D., Co-Investigators: Stephanie A. Jacobs M.D., Jocelyn B. Craig, M.D., Mihaela E. Nistor, Saba Motakef, Karen L. Noblett, M.D., and Hans Keirstead, M.D. Funded by Bayer HealthCare $110,000. Jul 1, 2009 - Jan 31, 2012 |
Prospective Randomized Controlled Trial Comparing Single Incision and Transobturator Midurethral Sling For Female Stress Urinary Incontinence. Principal Investigator Karen L. Noblett, M.D., Co-Investigator: Felicia L. Lane, M.D. Funded by Boston Scientific and the University of Chicago, Northshore. $27,282 Jul 1, 2009 - Mar 31, 2011 |
Comparison of Motor and Sensory Response with Interstim Stimulation for Overactive Bladder and Urgency-Frequency Syndrome. Principal Investigator Karen L. Noblett, M.D., Co-Investigators: Felicia L. Lane, M.D.; Ene G. George, M.D.; Danielle Markle, M.D., Jennifer K. Lee, M.D. Apr 1, 2009 - Feb 28, 2011 |
Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia: A randomized, Controlled, Cross-over Trial. Principal Investigator Felicia L. Lane, M.D., Co-Investigators: Karen L. Noblett, M.D., Danielle Markle, M.D, Ene G. George, M.D., Jennifer K. Lee, M.D., Julie Sarton, DPT, Patty Morita-Nagai, PT. Feb 1, 2009 - Feb 28, 2011 |
Injectable Myoblast for the Treatment of Anal Incontinence. Principal Investigator Felicia L. Lane, M.D., Co-Investigators Karen L. Noblett, M.D., Jocelyn B. Craig, M.D., and Hans Keirstead, M.D. Sep 1, 2008 - Sep 30, 2009 |
Allogenic Myoblast Transplantation in the Rat Anal Sphincter. Principal Investigator Felicia L. Lane M.D., Co-Investigators Jocelyn B. Craig, M.D., Mihaela E. Nistor, Saba Motakef, Karen L. Noblett, M.D., and Hans Keirstead, M.D. “Best Oral Paper Presentation” at 29th Annual American Urogynecologic Society Annual Scientific Meeting, Chicago, IL. Award: $500. Sep 1, 2008 - Sep 30, 2008 |
Lower Urinary Tract and Sexual Function in Women following Surgery for Colorectal Disorders. Principal Investigator Karen L. Noblett, M.D., Co-Investigators: Felicia L. Lane, M.D., Michael J. Stamos, M.D., Steven D. Mills, M.D. Funded by Perinatal Resources, Inc. $3,450 Apr 1, 2008 - Mar 31, 2011 |
Randomized Controlled Trial of Continuous vs. Cyclic Stimulation in Interstim Therapy. Principal Investigator Karen L. Noblett, M.D., Co-Investigators: Danielle Markle, M.D., Ene G. George, M.D., Felicia L. Lane, M.D., Jennifer K. Lee, M.D. Feb 1, 2008 - Jan 31, 2011 |
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment with Two Dose Levels of BOTOXP®P (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by Repeat Treatment with BOTOXP®P in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity. Principal Investigator Karen L. Noblett, M.D., Co-Investigators: Felicia Lane, M.D, Gaby Thai, M.D., Regina Hovey, M.D. Funded by Allergan, Inc. $618,491.40. Feb 1, 2008 - Dec 31, 2010 |
3-D Endo-Anal Ultrasound: Description of Normative Data Stratified by Age. Principal Investigator Karen Noblett, M.D., Co-Investigators Felicia L. Lane, M.D., Jocelyn B. Craig, M.D. Jan 1, 2008 - Nov 30, 2011 |
Myoblast Transplantation for the Treatment of Anal Incontinence. Principal Investigator Felicia L. Lane M.D., Co-Investigator Jocelyn B. Craig, M.D., Hans Keirstead, M.D. Grant Award: $4,100. Grant in Aid Recipient. Industry Sponsored $17,710.00. Sep 1, 2007 - Jul 31, 2011 |
Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates. Principal Investigator: Karen L. Noblett, M.D., Co-Investigators Felicia L. Lane, M.D., Laura Skoczylas, M.D Sep 1, 2007 - Dec 31, 2009 |
Prospective, Multicenter, Randomized, Parallel-Group Trial Comparing the Safety and Efficacy of InterStimP®P Therapy to Standard Medical Therapy for Subjects With Urinary Urgency Frequency Symptoms of Overactive Bladder. (InSite UI) Principal Investigator Karen L. Noblett, M.D., Co-Investigators Felicia Lane, M.D., Ene G. George, M.D. Industry Sponsored $122,318.50, 10/08. Jul 1, 2007 - Jul 31, 2011 |
Robotic-Assisted Laparoscopic Sacrocolpopexy: A Feasibility Study. Principal Investigator Felicia L. Lane M.D. May 1, 2007 - Oct 31, 2008 |
Trigger Point Injections with Pelvic Floor Physical Therapy for the Treatment of Vaginismus and Dyspareunia in Patients with Levator Myalgia. Principal Investigator Karen L. Noblett, M.D., Co-Investigators Felicia L. Lane, M.D., Patricia A. Wallace, M.D., Julie Sarton, DPT. Feb 1, 2007 - Aug 31, 2007 |
Reconstructive Pelvic Surgery and Plastic Surgery. A case-controlled study. Principal Investigator Felicia L. Lane, M.D., Co-Investigator Karen L. Noblett, M.D., Caroline Conner, M.D. and Jocelyn Craig, M.D. Jan 1, 2007 - Jan 31, 2008 |
Urinary Incontinence, Hormone Replacement Therapy and Physical Activity. Principal Investigator: Felicia L. Lane, M.D., Christopher Donnelly, M.D., Jocelyn B. Craig, M.D. Sep 1, 2006 - Sep 30, 2007 |
Sacral Nerve Stimulation for Urinary Control: Outcomes. Principal Investigator: Karen L. Noblett, M.D., Co-Investigators Felicia L. Lane, M.D., Patricia A. Wallace, M.D. Sep 1, 2006 - Sep 30, 2007 |
Does Fetal Head Circumference Predict Anal Sphincter Injury? A Prospective Study. Principal Investigator: Patricia A. Wallace, M.D. Co-Investigators: Felicia L. Lane, M.D. and Karen L. Noblett, M.D. May 1, 2006 - Jun 30, 2008 |
Traditional vs. Graft-Augmented Posterior Colporrhaphy: A Randomized Prospective Study. Principal Investigator: Karen L. Noblett, M.D., Co-Investigators: Felicia L. Lane, M.D., Amanda E. McKinney, M.D., Patricia A. Wallace, M.D., Ene G. George, M.D. Jan 1, 2006 - Dec 31, 2011 |
Prevalence of Lower Urinary Tract Symptoms in Women with Gynecologic Malignancy Planning to Undergo Surgical Management. Principal Investigator: Karen L. Noblett, M.D. Co-Investigators: Felicia L. Lane, M.D., et al Jan 1, 2006 - Feb 28, 2009 |
Grant Award Recipient: “A single-site, randomized, single-blinded, prospective study, comparing the recurrence rates at one year, of stage II posterior vaginal wall defects, who undergo traditional posterior colporrhaphy with bovine dermal xenograft augmentation, versus those who undergo a traditional posterior colporrhaphy without graft augmentation.” Principal Investigator: Karen L. Noblett, M.D., Co-Investigators: Felicia L. Lane, M.D., Amanda E. McKinney, M.D. Funded by Boston Scientific. $28,970 Jan 1, 2006 - Jan 31, 2007 |
Lynx: An Efficacious Alternative Midurethral Sling System? Principal Investigator: Karen L. Noblett, M.D., Co-Investigators Felicia L. Lane, M.D., Amanda E. McKinney, M.D., Betty Shen, M.D. Nov 1, 2005 - Apr 30, 2007 |
Randomized Controlled Trial Of Abdominal Versus Robotic-Assisted Laparoscopic Sacrocolpopexy. Principal Investigator Felicia L. Lane, M.D., Co-Investigator Karen L. Noblett, M.D. Jul 1, 2005 - Jul 31, 2006 |
Prospective Comparison of Open Abdominal Sacrocolpopexy Versus Robotic-Assisted Laparoscopic Sacrocolpopexy. Principal Investigator Felicia L. Lane, M.D., Co-Investigators: Karen L. Noblett, M.D., Ene G. George, M.D., Jennifer K. Lee, M.D Mar 1, 2005 - Mar 31, 2011 |
Incontinence Pessary: Can it Correct Urethral Hypermobility? Principal Investigator: Karen L. Noblett, M.D., Co-Investigators Amanda E. McKinney, M.D. and Felicia L. Lane, M.D. Oct 1, 2004 - Oct 31, 2005 |
Bion – An Implantable Microstimulation for the Chronic Treatment of Refractory Urinary Urge Incontinence. Principal Investigator Karen L. Noblett, M.D., Co-Investigator Felicia L. Lane, M.D. May 1, 2004 - Aug 31, 2005 |
Is Antenatal Fetal Head Circumference Predicative of Anal Sphincter Injury? Principal Investigator Karen L. Noblett, M.D., Co-Investigator Felicia L. Lane, M.D. Oct 1, 2002 - Oct 31, 2003 |
Faculty Career Development Award, Felicia L. Lane M.D. Award: $1,000 Mar 31, 2008 |